Foresite Capital Management VI as of June 30, 2025
Portfolio Holdings for Foresite Capital Management VI
Foresite Capital Management VI holds 20 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 32.5 | $58M | 2.2M | 26.00 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 9.3 | $17M | 1.3M | 13.14 | |
| Akero Therapeutics (AKRO) | 7.3 | $13M | 245k | 53.36 | |
| Alumis (ALMS) | 7.2 | $13M | 4.2M | 3.00 | |
| Rapt Therapeutics (RAPT) | 7.0 | $13M | 1.6M | 8.00 | |
| Bicara Therapeutics (BCAX) | 5.0 | $8.8M | 949k | 9.29 | |
| Edgewise Therapeutics (EWTX) | 4.3 | $7.7M | 585k | 13.11 | |
| Hinge Health Cl A (HNGE) | 3.9 | $7.0M | 135k | 51.75 | |
| Corvus Pharmaceuticals (CRVS) | 3.9 | $6.9M | 1.7M | 4.00 | |
| Kymera Therapeutics (KYMR) | 3.6 | $6.4M | 146k | 43.64 | |
| Verastem (VSTM) | 3.0 | $5.3M | 1.3M | 4.15 | |
| Xenon Pharmaceuticals (XENE) | 2.8 | $5.0M | 160k | 31.30 | |
| Cullinan Oncology (CGEM) | 2.5 | $4.5M | 594k | 7.53 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.4 | $4.4M | 210k | 20.74 | |
| Allogene Therapeutics (ALLO) | 1.8 | $3.2M | 2.9M | 1.13 | |
| Ideaya Biosciences (IDYA) | 1.7 | $3.0M | 145k | 21.02 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $1.1M | 40k | 28.40 | |
| Aeglea Biotherapeutics (SYRE) | 0.6 | $1.0M | 70k | 14.97 | |
| Casi Pharmaceuticals Ord Shs (CASI) | 0.5 | $929k | 787k | 1.18 | |
| Miragen Therapeutics (VRDN) | 0.0 | $28k | 2.0k | 13.98 |
